Psyllium and Pentam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Psyllium (blond psyllium) and Pentam (pentamidine isethionate). Common drug interactions include febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Psyllium and Pentam. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Psyllium?

Psyllium has active ingredients of blond psyllium. It is often used in constipation. eHealthMe is studying from 4,262 Psyllium users. Check the latest studies of Psyllium.

What is Pentam?

Pentam has active ingredients of pentamidine isethionate. eHealthMe is studying from 5,686 Pentam users. Check the latest studies of Pentam.



On Jul, 12, 2026

12 people who take Psyllium and Pentam together, and have interactions are studied.

Psyllium and Pentam drug interactions.

What are the common drug interactions of Psyllium and Pentam, by gender? *:

female:

n/a

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Cytomegalovirus enteritis (virus infection of intestine)
  3. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Generalised oedema (swelling all over the body)
  6. Diarrhoea
  7. Electrolyte imbalance
  8. Mycobacterium avium complex infection
  9. Renal failure (kidney dysfunction)
  10. Anaemia (lack of blood)

What are the common drug interactions of Psyllium and Pentam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 58.33%
  2. Migraine (headache): 4 people, 33.33%
  3. Hiv Infection: 4 people, 33.33%
  4. Diarrhea: 4 people, 33.33%
  5. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 4 people, 33.33%
  6. Back Pain: 4 people, 33.33%
  7. Asthma: 4 people, 33.33%
  8. Headache (pain in head): 2 people, 16.67%
  9. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Psyllium and Pentam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Psyllium and Pentam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Psyllium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pentam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Psyllium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pentam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on blond psyllium and pentamidine isethionate (the active ingredients of Psyllium and Pentam, respectively), and Psyllium and Pentam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: